HUM Humana Inc. Common Stock
NYSE · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Jul 29, 2026HUM Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
HUM Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 1 de Agosto de 1991 | 3-for-2 | Para frente |
| 1 de Fevereiro de 1984 | 6-for-5 | Para frente |
| 1 de Fevereiro de 1983 | 4-for-3 | Para frente |
| 1 de Fevereiro de 1982 | 3-for-2 | Para frente |
Sobre Humana Inc. Common Stock Visão geral da empresa da Wikipedia
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list. It is the fourth largest health insurance provider in the U.S.
History
1961–1983: Nursing homes and hospitals
Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).
In 1974, the partners changed the corporate name to Humana Inc. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s.
1984–present
As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."
In 1993, Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.
In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value.
In 2010, Humana returned to providing healthcare services when it bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million. They went on to sell Concentra again in 2015 for $1 billion.
In July 2015, Aetna announced that it would acquire Humana for $37 billion. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna and Humana cancelled a $34 billion merger agreement after judges ruled against the merger for a second time.
In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million.
In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO.
In 2024 Humana announced that they would be leaving the Humana Building, which they had occupied since the 1980s, in order to cut costs. Humana said that it planned to consolidate its workforce in its Waterside-Clocktower campus.
In 2026 KFF reported that Humana was the second-largest parent organization for Medicare Advantage by overall enrollment, and that it had the largest growth in that sector that year.
Humana Military Healthcare Services
In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.
In 2009, HMHS' contract with the military was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.
Legal campaign against drug price fixing
Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.
Controversy
In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.
On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.
In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.
Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.
On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | HUM | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 36.7média 5A ≈23.6 | ≈23.6 | 36.3 | Sobreavaliado | |
| P/S (TTM) | 0.5média 5A ≈0.7 | ≈0.7 | 0.7 | Subvalorizado | |
| P/B (MRQ) | 4.0média 5A ≈4.6 | ≈4.6 | 3.9 | Valor justo | |
| EV / EBITDA | 25.8média 5A ≈19.0 | ≈19.0 | 16.1 | Valor justo | |
| Preço / FCF (TTM) | 39.6média 5A ≈54.2 | ≈54.2 | · | · | |
| Preço / Fluxo de Caixa (TTM) | 30.4média 5A ≈29.3 | ≈29.3 | 15.6 | Sobreavaliado | |
| EV / Receita (TTM) | 0.4média 5A ≈0.6 | ≈0.6 | · | · | |
| EV / FCF (TTM) | 33.5média 5A ≈46.5 | ≈46.5 | · | · | |
| Preço / Valor Patrimonial Tangível (MRQ) | 4.3média 5A ≈14.5 | ≈14.5 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | HUM | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | 1.9%média 5A ≈3.2% | ≈3.2% | 3.5% | Fraco | |
| EBITDA Margin (Margem EBITDA) | 2.1%média 5A ≈3.2% | ≈3.2% | 3.7% | Fraco | |
| Margem de Impostos Pré-Tributação (TTM) | 1.1%média 5A ≈2.7% | ≈2.7% | 2.8% | Fraco | |
| Margem de Lucro Líquido (TTM) | 0.88%média 5A ≈2.2% | ≈2.2% | 2.9% | Fraco | |
| ROA (TTM) | 2.4%média 5A ≈4.9% | ≈4.9% | 3.0% | Fraco | |
| ROE (TTM) | 6.8%média 5A ≈13.3% | ≈13.3% | 10.1% | Fraco | |
| ROIC | 7.4%média 5A ≈9.7% | ≈9.7% | 8.0% | Fraco |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | HUM | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido (MRQ) | 0.6média 5A ≈0.7 | ≈0.7 | 0.7 | Baixa dívida | |
| Índice de liquidez corrente (MRQ) | 1.7média 5A ≈1.7 | ≈1.7 | 1.7 | Liquidez forte | |
| Índice de Liquidez Seca (MRQ) | 1.3média 5A ≈1.3 | ≈1.3 | 1.3 | Em linha | |
| Dívida de Longo Prazo / Patrimônio Líquido (MRQ) | 0.6média 5A ≈0.7 | ≈0.7 | 0.7 | Baixa dívida |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | HUM | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 10.1%média 5A ≈11.0% | ≈11.0% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 11.8%média 5A ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 10.9% | · | · | · | |
| EPS YoY | -1.4%média 5A ≈-14.8% | ≈-14.8% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | -1.6%média 5A ≈-16.3% | ≈-16.3% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | -23.6%média 5A ≈-18.4% | ≈-18.4% | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | -17.2% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | -24.9%média 5A ≈-20.0% | ≈-20.0% | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | -18.8% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | HUM | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 2.7média 5A ≈2.4 | ≈2.4 | 2.4 | Em linha | |
| Receivables Turnover (Giro de Contas a Receber) | 43.4média 5A ≈52.0 | ≈52.0 | 16.3 | Primeira linha | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$1.9M | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor | Moeda | Rendimento |
|---|---|---|---|
| Jun 26, 2026 | $0,89 | USD | ≈0.92% |
| Mar 27, 2026 | $0,89 | USD | ≈2.1% |
| Dez 26, 2025 | $0,89 | USD | ≈1.4% |
| Set 26, 2025 | $0,89 | USD | ≈1.4% |
| Jun 27, 2025 | $0,89 | USD | ≈1.5% |
| Mar 28, 2025 | $0,89 | USD | ≈1.3% |
| Dez 31, 2024 | $0,89 | USD | ≈1.4% |
| Set 30, 2024 | $0,89 | USD | ≈1.1% |
| Jun 28, 2024 | $0,89 | USD | ≈0.95% |
| Mar 27, 2024 | $0,89 | USD | ≈1.0% |
| Dez 28, 2023 | $0,89 | USD | ≈0.78% |
| Set 28, 2023 | $0,89 | USD | ≈0.70% |
| Jun 29, 2023 | $0,89 | USD | ≈0.75% |
| Mar 30, 2023 | $0,89 | USD | ≈0.67% |
| Dez 29, 2022 | $0,79 | USD | ≈0.61% |
| Set 29, 2022 | $0,79 | USD | ≈0.62% |
| Jun 29, 2022 | $0,79 | USD | ≈0.64% |
| Mar 30, 2022 | $0,79 | USD | ≈0.66% |
| Dez 30, 2021 | $0,70 | USD | ≈0.60% |
| Set 29, 2021 | $0,70 | USD | ≈0.69% |
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Jul 29, 2026 | $7.61 | $7.29 | 4.3% |
| 31 de Março de 2026 | $10.31 | $10.29 | 0.21% | |
| 31 de Dezembro de 2025 | $-3.96 | $-4.05 | 2.1% | |
| 30 de Setembro de 2025 | $3.24 | $2.85 | 13.8% | |
| 30 de Junho de 2025 | $6.27 | $5.98 | 4.9% | |
| 31 de Março de 2025 | $11.58 | $10.17 | 13.9% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $88.85 | $82.40 | $81.85 | $77.07 | · | · | · | · | · | · | · | · | |
| Revenue / Share | $1073.15 | $974.29 | $854.81 | $730.72 | $641.94 | $580.06 | $481.63 | $411.20 | $369.32 | $360.32 | $359.19 | $311.15 | |
| Cash Flow / Share | $7.62 | $24.54 | $31.99 | $36.09 | $17.48 | $42.39 | $39.22 | $15.70 | $27.83 | $12.83 | $5.74 | $10.38 | |
| Cash / Share | $21.14 | $11.18 | $23.62 | $25.47 | · | · | · | · | · | · | · | · | |
| Dividend / Share | · | · | · | · | · | · | · | · | · | $1.16 | $1.15 | $1.11 | |
| Dividend Paid / Share | $3.54 | $3.54 | $3.44 | $3.06 | $2.73 | $2.43 | $2.15 | $1.90 | $1.49 | $1.16 | $1.14 | $1.10 | |
| EPS (TTM) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | · | 120,273,000 | 120,539,000 | 120,666,000 | · | 120,405,000 | 120,445,000 | 120,978,000 | · | 123,426,000 | 124,574,000 | 125,005,000 | · | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | · | 120,745,000 | 120,745,000 | 120,844,000 | · | 120,764,000 | 120,665,000 | 121,268,000 | · | 123,983,000 | 125,109,000 | 125,564,000 | · | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $96.68 | $93.50 | · | $93.21 | $91.76 | $89.33 | · | $88.39 | $83.89 | $81.18 | · | $85.30 | $84.72 | $83.44 | · | $82.13 | |
| Revenue / Share | $337.37 | $328.61 | · | $270.40 | $268.23 | $265.73 | · | $243.43 | $244.81 | $244.18 | · | $213.12 | $213.79 | $212.98 | · | $179.02 | |
| Cash Flow / Share | · | $10.39 | · | · | · | $2.74 | · | · | · | $3.49 | · | · | · | $53.26 | · | · | |
| Cash / Share | $34.69 | $24.91 | · | $27.11 | $20.33 | $21.39 | · | $25.74 | $27.68 | $29.74 | · | $76.24 | $81.60 | $69.14 | · | $68.24 | |
| Dividend / Share | $0.89 | $0.89 | $0.89 | · | · | $0.89 | $0.89 | · | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | $0.89 | · | · | · | · | · | · | |
| EPS (TTM) | $10.59 | $9.37 | · | $10.70 | $13.06 | $14.17 | · | $11.47 | $14.20 | $16.24 | · | $24.16 | $26.84 | $24.66 | · | $22.05 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.68B | $137.20B | · | $126.36B | $123.11B | $120.26B | · | $115.01B | $112.04B | $109.24B | · | $102.35B | $98.73B | $95.64B | · | $91.48B | |
| Net Income TTM | $1.28B | $1.13B | · | $1.29B | $1.58B | $1.71B | · | $1.36B | $1.71B | $1.99B | · | $3.02B | $3.38B | $3.12B | · | $2.81B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 37.5 | 18.5 | · | 24.3 | 18.7 | 18.7 | · | 27.6 | 26.3 | 21.3 | · | 20.1 | 16.7 | 19.7 | · | 22.0 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | |
| Dividend Yield | 0.54% | 1.2% | · | 0.83% | 0.88% | 0.82% | · | 0.69% | 0.59% | 0.64% | · | 0.44% | 0.46% | 0.42% | · | 0.40% | |
| Earnings Yield | 2.7% | 5.4% | · | 4.1% | 5.3% | 5.4% | · | 3.6% | 3.8% | 4.7% | · | 5.0% | 6.0% | 5.1% | · | 4.5% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · | |
| Annual Payout | $430M | $429M | · | $429M | $429M | $430M | · | $434M | $436M | $440M | · | $421M | $412M | $401M | · | $382M |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Margem Operacional % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| Lucro líquido | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| EPS Diluído | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| Índice de liquidez corrente | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| Índice de Liquidez Seca | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $375M | $2.39B | $2.98B | $3.47B | $946M |
Investidores institucionais (13F) 1.038 declarantes · $52.7B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 248 (+126 vs trimestre anterior) | 85 (-76 vs trimestre anterior) | 325 (+68 vs trimestre anterior) | 288 (-56 vs trimestre anterior) | +3.9M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Dodge & Cox | $4.345.737.744 | 10.940.380 | 8,25% | Ações |
| BlackRock, Inc. | $4.138.159.785 | 10.417.803 | 7,85% | Ações |
| VANGUARD GROUP INC | $3.652.890.202 | 14.261.860 | 6,93% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.115.642.737 | 7.843.620 | 5,91% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.311.405.702 | 5.818.956 | 4,39% | Ações |
| STATE STREET CORP | $2.172.441.313 | 5.457.072 | 4,12% | Ações |
| PZENA INVESTMENT MANAGEMENT LLC | $1.749.013.682 | 4.403.136 | 3,32% | Ações |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1.664.784.292 | 3.578.245 | 3,16% | Ações |
| EAGLE CAPITAL MANAGEMENT LLC | $1.528.010.749 | 3.846.762 | 2,90% | Ações |
| Sessa Capital IM, L.P. | $1.480.732.883 | 3.727.740 | 2,81% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $1.337.386.742 | 3.369.757 | 2,54% | Ações |
| JPMORGAN CHASE & CO | $1.257.951.102 | 3.234.637 | 2,39% | Ações |
| FMR LLC | $1.157.405.236 | 2.913.763 | 2,20% | Ações |
| Capital International Investors | $950.462.637 | 2.392.826 | 1,80% | Ações |
| GOLDMAN SACHS GROUP INC | $913.562.254 | 2.299.889 | 1,73% | Ações |
| NAYA CAPITAL MANAGEMENT UK LTD | $728.407.339 | 1.833.763 | 1,38% | Ações |
| NORGES BANK | $694.505.009 | 1.748.414 | 1,32% | Ações |
| Invesco Ltd. | $587.403.999 | 1.478.788 | 1,11% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544.521.489 | 1.370.831 | 1,03% | Ações |
| MORGAN STANLEY | $535.876.914 | 1.349.066 | 1,02% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $445.839.059 | 1.122.669 | 0,85% | Ações |
| Capital Research Global Investors | $443.462.035 | 1.116.990 | 0,84% | Ações |
| NORTHERN TRUST CORP | $442.978.948 | 1.115.198 | 0,84% | Ações |
| Slate Path Capital LP | $428.969.795 | 1.079.930 | 0,81% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $423.436.520 | 1.066.000 | 0,80% | Opção de venda |
| Capital World Investors | $406.119.738 | 1.022.425 | 0,77% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $399.841.652 | 1.006.600 | 0,76% | Opção de compra |
| Newport Trust Company, LLC | $384.768.345 | 968.653 | 0,73% | Ações |
| CITADEL ADVISORS LLC | $363.376.856 | 914.800 | 0,69% | Opção de compra |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348.908.912 | 878.377 | 0,66% | Ações |
| Legal & General Group Plc | $329.760.125 | 830.170 | 0,63% | Ações |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314.921.577 | 792.814 | 0,60% | Ações |
| CITADEL ADVISORS LLC | $310.904.094 | 782.700 | 0,59% | Opção de venda |
| Allianz Asset Management GmbH | $307.098.329 | 773.119 | 0,58% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $304.014.312 | 765.355 | 0,58% | Ações |
| BANK OF AMERICA CORP /DE/ | $279.490.113 | 703.615 | 0,53% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $267.791.027 | 674.163 | 0,51% | Ações |
| Maple Rock Capital Partners Inc. | $249.553.862 | 628.251 | 0,47% | Ações |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245.555.446 | 618.185 | 0,47% | Ações |
| Bank of New York Mellon Corp | $238.144.113 | 599.527 | 0,45% | Ações |
| GOLDMAN SACHS GROUP INC | $232.333.978 | 584.900 | 0,44% | Opção de compra |
| MARSHALL WACE, LLP | $216.873.381 | 545.978 | 0,41% | Ações |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $189.649.820 | 1.093.776 | 0,36% | Ações |
| CITADEL ADVISORS LLC | $178.360.519 | 449.022 | 0,34% | Ações |
| High Ground Investment Management LLP | $177.941.848 | 447.968 | 0,34% | Ações |
| 1832 Asset Management L.P. | $176.401.430 | 444.090 | 0,33% | Ações |
| BCV Asset Management Inc. | $173.695.656 | 445.719 | 0,33% | Ações |
| Nuveen, LLC | $167.646.743 | 422.051 | 0,32% | Ações |
| Holocene Advisors, LP | $165.040.541 | 415.489 | 0,31% | Ações |
| DEUTSCHE BANK AG\ | $163.345.207 | 411.221 | 0,31% | Ações |
Ativistas e proprietários de 5%+ 1 participação
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| David A. Jones ×2 declarações | 12 de Novembro de 2003 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 79 insiders · 48 diretores · 29 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | 1 de Maio de 2026 A | 63.938 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | 21 de Fevereiro de 2024 A | 110.130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | 1 de Maio de 2026 A | 39.637 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | 31 de Dezembro de 2024 J | 20.165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | 22 de Fevereiro de 2021 A | 24.342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | 9 de Maio de 2014 G | 14.916 | 0 | 0 | $0 |
| Aaron Martin | President, Medicare Advantage | 1 de Maio de 2026 A | 25.237 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | 1 de Maio de 2026 A | 25.407 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | 1 de Maio de 2026 A | 22.088 | 1 | 0 | $150.012 |
| George Renaudin II | President, Insurance | 31 de Março de 2026 J | 16.075 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | 24 de Fevereiro de 2023 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | 15 de Dezembro de 2022 M | 3.983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | 15 de Dezembro de 2017 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | 18 de Fevereiro de 2014 A | 105.443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | 31 de Março de 2017 J | 34.668 | 0 | 0 | $0 |
| Shantanu Nundy | Chief Medical Officer | 1 de Setembro de 2026 A | 2.549 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | 1 de Maio de 2026 A | 17.176 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | 1 de Maio de 2026 A | 20.026 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | 1 de Maio de 2026 A | 27.405 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 24 de Fevereiro de 2026 F | 7.484 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 24 de Fevereiro de 2025 A | 16.717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | 31 de Dezembro de 2024 G | 7.111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | 15 de Dezembro de 2024 M | 14.015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | 21 de Fevereiro de 2024 A | 11.723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | 24 de Fevereiro de 2023 F | 3.687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | 1 de Maio de 2022 M | 4.294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | 22 de Março de 2022 J | 5.723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | 25 de Fevereiro de 2022 F | 6.014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | 16 de Março de 2021 G | 8.168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | 18 de Dezembro de 2019 M | 18.092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | 15 de Dezembro de 2019 M | 6.339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | 25 de Fevereiro de 2019 A | 9.774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | 19 de Fevereiro de 2019 M | 10.791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | 15 de Dezembro de 2018 M | 11.136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | 15 de Dezembro de 2018 M | 6.476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | 17 de Março de 2017 M | 4.361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | 18 de Fevereiro de 2014 A | 1.101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | 18 de Fevereiro de 2014 A | 15.946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | 24 de Junho de 2013 M | 19.347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | 24 de Dezembro de 2012 G | 2.287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | 28 de Abril de 2012 F | 11.946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | 23 de Fevereiro de 2012 A | 23.280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | 4 de Fevereiro de 2009 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | 27 de Março de 2008 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | 25 de Fevereiro de 2008 F | 13.836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | 31 de Dezembro de 2007 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | 23 de Fevereiro de 2007 M | 57.548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | 6 de Janeiro de 2005 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | Conselheiro | 30 de Setembro de 2026 A | 19.448 | 0 | 0 | $0 |
| Paul John Smith | Conselheiro | 1 de Agosto de 2026 A | 544 | 0 | 0 | $0 |
| Robert Stuart Field | Conselheiro | 1 de Maio de 2026 A | 852 | 0 | 0 | $0 |
| Jorge S. Mesquita | Conselheiro | 2 de Janeiro de 2026 A | 4.127 | 0 | 0 | $0 |
| Frank A Damelio | Conselheiro | 2 de Janeiro de 2026 A | 20.634 | 0 | 0 | $0 |
| Raquel C. Bono | Conselheiro | 31 de Dezembro de 2025 A | 397 | 0 | 0 | $0 |
| Wayne A.I. Frederick | Conselheiro | 31 de Dezembro de 2025 A | 440 | 0 | 0 | $0 |
| Marcy S Klevorn | Conselheiro | 31 de Dezembro de 2025 A | 436 | 0 | 0 | $0 |
| John W Garratt | Conselheiro | 31 de Dezembro de 2025 A | 1.685 | 0 | 0 | $0 |
| David T Feinberg | Conselheiro | 31 de Dezembro de 2025 A | 1.207 | 0 | 0 | $0 |
| Karen Katz | Conselheiro | 31 de Dezembro de 2025 A | 590 | 0 | 0 | $0 |
| Brad D Smith | Conselheiro | 31 de Dezembro de 2024 A | 1.169 | 0 | 0 | $0 |
| William J. Mcdonald | Conselheiro | 2 de Janeiro de 2024 A | 2.276 | 0 | 0 | $0 |
| JONES DAVID A JR/KY | Conselheiro | 28 de Fevereiro de 2023 G | 32.440 | 0 | 0 | $0 |
| OBRIEN JAMES J /KY | Conselheiro | 3 de Janeiro de 2023 A | 1.794 | 0 | 0 | $0 |
| Marissa T Peterson | Conselheiro | 3 de Janeiro de 2022 A | 2.044 | 0 | 0 | $0 |
| Frank Bisignano | Conselheiro | 4 de Janeiro de 2021 A | 2.727 | 0 | 0 | $0 |
| Webster Roy Dunbar | Conselheiro | 31 de Dezembro de 2019 A | 2.880 | 0 | 0 | $0 |
| Karen B Desalvo | Conselheiro | 2 de Janeiro de 2019 A | 634 | 0 | 0 | $0 |
| David Nash | Conselheiro | 2 de Janeiro de 2019 A | 112 | 0 | 0 | $0 |
| William Mitchell | Conselheiro | 31 de Dezembro de 2018 A | 688 | 0 | 0 | $0 |
| Michael B Mccallister | Conselheiro | 31 de Dezembro de 2013 M | 113.885 | 0 | 0 | $0 |
| Ann W Reynolds | Conselheiro | 15 de Maio de 2011 M | 39.727 | 0 | 0 | $0 |
| James O Robbins | Conselheiro | 3 de Janeiro de 2007 A | · | 0 | 0 | $0 |
| HALL JOHN R /KY | Conselheiro | 3 de Janeiro de 2006 A | 22.423 | 0 | 0 | $0 |
| JONES DAVID A SR/KY | Conselheiro | 5 de Abril de 2005 G | 4.777.524 | 0 | 0 | $0 |
| Michael E Gellert | Conselheiro | 3 de Janeiro de 2005 A | 60.237 | 0 | 0 | $0 |
| Irwin Lerner | Conselheiro | 2 de Janeiro de 2004 A | 30.637 | 0 | 0 | $0 |
| Frederick John Crawford | · | 1 de Agosto de 2026 A | 544 | 0 | 0 | $0 |
| Gordon Smith | · | 31 de Dezembro de 2025 A | 765 | 0 | 0 | $0 |
| James H Bloem | · | 7 de Novembro de 2013 M | 30.326 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 143 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IHF · iShares Trust | 4,63% | 151.582 SH | 11 de Setembro de 2026 | Diário |
| FMTM · EA Series Trust | 3,07% | 21.303 NS | 31 de Julho de 2026 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 2,57% | 1.854 NS | 31 de Julho de 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2,35% | 103.450 SH | 2 de Outubro de 2026 | Diário |
| SRHQ · Elevation Series Trust | 2,31% | 13.473 NS | 31 de Julho de 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,75% | 225 NS | 31 de Julho de 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1,71% | 2.014 NS | 31 de Julho de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,57% | 35.951 SH | 2 de Outubro de 2026 | Diário |
| NUMV · Nushares ETF Trust | 1,39% | 16.939 NS | 31 de Julho de 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,16% | 290 NS | 31 de Julho de 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,88% | 32.276 NS | 31 de Julho de 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,82% | 771.237 SH | 19 de Agosto de 2026 | Diário |
| IYH · iShares Trust | 0,78% | 70.303 SH | 11 de Setembro de 2026 | Diário |
| JOET · Virtus ETF Trust II | 0,74% | 4.940 NS | 31 de Julho de 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,74% | 4.248 NS | 31 de Julho de 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,71% | 181.374 SH | 2 de Outubro de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,70% | 360.880 SH | 19 de Agosto de 2026 | Diário |
| PDP · Invesco Exchange-Traded Fund Trust | 0,70% | 27.208 SH | 2 de Outubro de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,63% | 57.108 NS | 31 de Julho de 2026 | N-PORT |
| IXJ · iShares Trust | 0,61% | 63.215 SH | 11 de Setembro de 2026 | Diário |
| CURE · Direxion Shares ETF Trust | 0,50% | 2.362 NS | 31 de Julho de 2026 | N-PORT |
| IWS · iShares Trust | 0,47% | 179.478 SH | 11 de Setembro de 2026 | Diário |
| VO · VANGUARD INDEX FUNDS | 0,46% | 2.601.869 SH | 19 de Agosto de 2026 | Diário |
| IMCV · iShares Trust | 0,40% | 11.586 SH | 11 de Setembro de 2026 | Diário |
| MTUM · iShares Trust | 0,37% | 227.558 SH | 11 de Setembro de 2026 | Diário |
| IWR · iShares Trust | 0,35% | 492.212 SH | 11 de Setembro de 2026 | Diário |
| PRF · Invesco Exchange-Traded Fund Trust | 0,34% | 88.063 SH | 2 de Outubro de 2026 | Diário |
| IMCB · iShares Trust | 0,34% | 14.123 SH | 11 de Setembro de 2026 | Diário |
| VRP · Invesco Exchange-Traded Fund Trust … | 0,33% | 10.420.000 | 2 de Outubro de 2026 | Diário |
| FFLC · FIDELITY COVINGTON TRUST | 0,32% | 10.722 NS | 31 de Julho de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,32% | 8.116 SH | 2 de Outubro de 2026 | Diário |
| IMCG · iShares Trust | 0,27% | 27.157 SH | 11 de Setembro de 2026 | Diário |
| XOEF · iShares Trust | 0,27% | 151 SH | 11 de Setembro de 2026 | Diário |
| VLUE · iShares Trust | 0,26% | 62.879 SH | 11 de Setembro de 2026 | Diário |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,25% | 320.000 | 2 de Outubro de 2026 | Diário |
| SIZE · iShares Trust | 0,24% | 2.599 SH | 11 de Setembro de 2026 | Diário |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,23% | 8.027.000 | 2 de Outubro de 2026 | Diário |
| ROUS · Lattice Strategies Trust | 0,23% | 4.462 NS | 31 de Julho de 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,22% | 9.983.000 | 2 de Outubro de 2026 | Diário |
| EUSA · iShares, Inc. | 0,22% | 10.324 SH | 11 de Setembro de 2026 | Diário |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 26.395 NS | 31 de Julho de 2026 | N-PORT |
| CATH · Global X Funds | 0,21% | 7.419 NS | 31 de Julho de 2026 | N-PORT |
| VYM · VANGUARD WHITEHALL FUNDS | 0,20% | 479.438 SH | 19 de Agosto de 2026 | Diário |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 487.833 SH | 2 de Outubro de 2026 | Diário |
| EVUS · iShares Trust | 0,19% | 1.842 SH | 11 de Setembro de 2026 | Diário |
| USXF · iShares Trust | 0,19% | 7.125 SH | 11 de Setembro de 2026 | Diário |
| ESMV · iShares Trust | 0,19% | 37 SH | 11 de Setembro de 2026 | Diário |
| SUSA · iShares Trust | 0,19% | 19.078 SH | 11 de Setembro de 2026 | Diário |
| ACVF · ETF Opportunities Trust | 0,19% | 790 NS | 31 de Julho de 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,18% | 1.140.642 SH | 19 de Agosto de 2026 | Diário |
| DFLV · Dimensional ETF Trust | 0,18% | 32.943 NS | 31 de Julho de 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 3.921 NS | 31 de Julho de 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,17% | 3.648 SH | 19 de Agosto de 2026 | Diário |
| DFSU · Dimensional ETF Trust | 0,17% | 10.472 NS | 31 de Julho de 2026 | N-PORT |
| IVE · iShares Trust | 0,16% | 200.080 SH | 11 de Setembro de 2026 | Diário |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,16% | 27.648 SH | 19 de Agosto de 2026 | Diário |
| IUSV · iShares Trust | 0,15% | 104.740 SH | 11 de Setembro de 2026 | Diário |
| VEGN · ETF Series Solutions | 0,15% | 709 NS | 31 de Julho de 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,14% | 60.086 NS | 31 de Julho de 2026 | N-PORT |
| SUSL · iShares Trust | 0,14% | 4.238 SH | 11 de Setembro de 2026 | Diário |
| FYEE · Fidelity Greenwood Street Trust | 0,14% | 839 NS | 31 de Julho de 2026 | N-PORT |
| DSI · iShares Trust | 0,14% | 18.418 SH | 11 de Setembro de 2026 | Diário |
| IQSU · New York Life Investments ETF Trust | 0,14% | 1.230 NS | 31 de Julho de 2026 | N-PORT |
| CHRI · Global X Funds | 0,13% | 29 NS | 31 de Julho de 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,13% | 72.504 SH | 19 de Agosto de 2026 | Diário |
| IWD · iShares Trust | 0,13% | 267.199 SH | 11 de Setembro de 2026 | Diário |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,12% | 3.809.000 | 2 de Outubro de 2026 | Diário |
| NULV · Nushares ETF Trust | 0,11% | 6.797 NS | 31 de Julho de 2026 | N-PORT |
| ESGU · iShares Trust | 0,11% | 47.962 SH | 11 de Setembro de 2026 | Diário |
| DGRO · iShares Trust | 0,10% | 111.232 SH | 11 de Setembro de 2026 | Diário |
| EGLE · Global X Funds | 0,10% | 6 NS | 31 de Julho de 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,10% | 3 NS | 31 de Julho de 2026 | N-PORT |
| LQAI · Exchange Listed Funds Trust | 0,10% | 6 NS | 31 de Julho de 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 1.886 SH | 2 de Outubro de 2026 | Diário |
| TOPC · iShares Trust | 0,09% | 72 SH | 11 de Setembro de 2026 | Diário |
| ILCV · iShares Trust | 0,08% | 2.783 SH | 11 de Setembro de 2026 | Diário |
| XVV · iShares Trust | 0,08% | 1.375 SH | 11 de Setembro de 2026 | Diário |
| VV · VANGUARD INDEX FUNDS | 0,08% | 140.219 SH | 19 de Agosto de 2026 | Diário |
| ESGV · VANGUARD WORLD FUND | 0,08% | 27.152 SH | 19 de Agosto de 2026 | Diário |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,08% | 3.447 SH | 2 de Outubro de 2026 | Diário |
| DFAC · Dimensional ETF Trust | 0,08% | 100.648 NS | 31 de Julho de 2026 | N-PORT |
| XTR · Global X Funds | 0,08% | 10 NS | 31 de Julho de 2026 | N-PORT |
| IVV · iShares Trust | 0,07% | 1.513.176 SH | 11 de Setembro de 2026 | Diário |
| ILCB · iShares Trust | 0,07% | 2.328 SH | 11 de Setembro de 2026 | Diário |
| XCLR · Global X Funds | 0,07% | 7 NS | 31 de Julho de 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,07% | 3.119.147 SH | 19 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,07% | 3.812.375 SH | 19 de Agosto de 2026 | Diário |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,07% | 19.809 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,07% | 10.113 SH | 19 de Agosto de 2026 | Diário |
| PBP · Invesco Exchange-Traded Fund Trust | 0,07% | 715 SH | 2 de Outubro de 2026 | Diário |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,07% | 20.848 SH | 2 de Outubro de 2026 | Diário |
| IYY · iShares Trust | 0,07% | 5.172 SH | 11 de Setembro de 2026 | Diário |
| IWB · iShares Trust | 0,07% | 82.919 SH | 11 de Setembro de 2026 | Diário |
| XYLD · Global X Funds | 0,07% | 6.091 NS | 31 de Julho de 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,07% | 6.112 NS | 31 de Julho de 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 16.615 NS | 31 de Julho de 2026 | N-PORT |
| USCL · iShares Trust | 0,07% | 4.768 SH | 11 de Setembro de 2026 | Diário |
| VOTE · TCW ETF Trust | 0,07% | 2.035 NS | 31 de Julho de 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,07% | 10.127 NS | 31 de Julho de 2026 | N-PORT |
| XRMI · Global X Funds | 0,07% | 92 NS | 31 de Julho de 2026 | N-PORT |
| IWV · iShares Trust | 0,07% | 33.101 SH | 11 de Setembro de 2026 | Diário |
| ITOT · iShares Trust | 0,07% | 156.223 SH | 11 de Setembro de 2026 | Diário |
| LRGF · iShares Trust | 0,06% | 5.842 SH | 11 de Setembro de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,06% | 959 NS | 31 de Julho de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,06% | 36.333 NS | 31 de Julho de 2026 | N-PORT |
| XYLG · Global X Funds | 0,06% | 111 NS | 31 de Julho de 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,06% | 453 NS | 31 de Julho de 2026 | N-PORT |
| ILCG · iShares Trust | 0,06% | 4.804 SH | 11 de Setembro de 2026 | Diário |
| QDPL · Pacer Funds Trust | 0,06% | 2.883 NS | 31 de Julho de 2026 | N-PORT |
| TOV · EA Series Trust | 0,06% | 454 NS | 31 de Julho de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,06% | 3.564 NS | 31 de Julho de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,06% | 20.053 NS | 31 de Julho de 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,06% | 95 SH | 2 de Outubro de 2026 | Diário |
| VOXP · Advisors Series Trust | 0,06% | 9 NS | 31 de Julho de 2026 | N-PORT |
| TOK · iShares Trust | 0,06% | 333 SH | 11 de Setembro de 2026 | Diário |
| HCMT · Direxion Shares ETF Trust | 0,05% | 835 NS | 31 de Julho de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,05% | 4.948 NS | 31 de Julho de 2026 | N-PORT |
| URTH · iShares, Inc. | 0,05% | 10.772 SH | 11 de Setembro de 2026 | Diário |
| SPXL · Direxion Shares ETF Trust | 0,05% | 9.382 NS | 31 de Julho de 2026 | N-PORT |
| ACWI · iShares Trust | 0,05% | 38.539 SH | 11 de Setembro de 2026 | Diário |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,04% | 196.805 SH | 19 de Agosto de 2026 | Diário |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,04% | 4.718 SH | 2 de Outubro de 2026 | Diário |
| NEAR · iShares U.S. ETF Trust | 0,03% | 1.504.000 SH | 11 de Setembro de 2026 | Diário |
| GLOF · iShares Trust | 0,02% | 106 SH | 11 de Setembro de 2026 | Diário |
| DYNF · BlackRock ETF Trust | 0,01% | 14.919 SH | 11 de Setembro de 2026 | Diário |
| CRBN · iShares Trust | 0,01% | 383 SH | 11 de Setembro de 2026 | Diário |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 4.397.881 SH | 19 de Agosto de 2026 | Diário |
| VPL · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 401.850 SH | 19 de Agosto de 2026 | Diário |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 932.492 SH | 19 de Agosto de 2026 | Diário |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 2.391.019 SH | 19 de Agosto de 2026 | Diário |
| VSGX · VANGUARD WORLD FUND | 0,00% | 54.062 SH | 19 de Agosto de 2026 | Diário |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de Julho de 2026 | Diário |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 de Julho de 2026 | Diário |
| VCEB · VANGUARD WORLD FUND | · | · | 30 de Julho de 2026 | Diário |
HUM Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
Preço-alvo de 12 meses
23 analistas · 2026-09-30Alvo médio $423.74 +9,1%
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.